These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 35401833)

  • 1. Theranostic nanoparticles for the management of thrombosis.
    Russell P; Hagemeyer CE; Esser L; Voelcker NH
    Theranostics; 2022; 12(6):2773-2800. PubMed ID: 35401833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy.
    Zhu L; Zhou Z; Mao H; Yang L
    Nanomedicine (Lond); 2017 Jan; 12(1):73-87. PubMed ID: 27876448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Combination of Solid-State Chemistry and Medicinal Chemistry as the Basis for the Synthesis of Theranostics Platforms.
    Korolev D; Postnov V; Aleksandrov I; Murin I
    Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theranostic Nanomedicine; A Next Generation Platform for Cancer Diagnosis and Therapy.
    Sharma R; Mody N; Agrawal U; Vyas SP
    Mini Rev Med Chem; 2017; 17(18):1746-1757. PubMed ID: 26891932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticle Diagnostics and Theranostics in the Clinic.
    Pallares RM; Mottaghy FM; Schulz V; Kiessling F; Lammers T
    J Nucl Med; 2022 Dec; 63(12):1802-1808. PubMed ID: 36302654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic nanoparticles for cancer theranostics: Advances and prospects.
    Li X; Li W; Wang M; Liao Z
    J Control Release; 2021 Jul; 335():437-448. PubMed ID: 34081996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticle theranostics in cardiovascular inflammation.
    MacRitchie N; Di Francesco V; Ferreira MFMM; Guzik TJ; Decuzzi P; Maffia P
    Semin Immunol; 2021 Aug; 56():101536. PubMed ID: 34862118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombus-specific theranostic nanocomposite for codelivery of thrombolytic drug, algae-derived anticoagulant and NIR fluorescent contrast agent.
    Chang LH; Chuang EY; Cheng TM; Lin C; Shih CM; Wu AT; Jheng PR; Lu HY; Shih CC; Mi FL
    Acta Biomater; 2021 Oct; 134():686-701. PubMed ID: 34358695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voyage of theranostic liposomes for imaging and therapy.
    Sachin M; Sachin D; Dinesh S
    J Cosmet Laser Ther; 2017 Aug; 19(4):245-249. PubMed ID: 28135901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive approach of hybrid nanoplatforms in drug delivery and theranostics to combat cancer.
    Thorat ND; Townley HE; Patil RM; Tofail SAM; Bauer J
    Drug Discov Today; 2020 Jul; 25(7):1245-1252. PubMed ID: 32371139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theranostics Nanomedicine Applications for Colorectal Cancer and Metastasis: Recent Advances.
    Kasi PB; Mallela VR; Ambrozkiewicz F; Trailin A; Liška V; Hemminki K
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. All-in-One Nanomedicine: Multifunctional Single-Component Nanoparticles for Cancer Theranostics.
    Cai Y; Chen X; Si J; Mou X; Dong X
    Small; 2021 Dec; 17(52):e2103072. PubMed ID: 34561968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent Advances in Theranostic Applications of Nanomaterials in Cancer.
    Ahmed F; Khan MA; Haider N; Ahmad MZ; Ahmad J
    Curr Pharm Des; 2022; 28(2):133-150. PubMed ID: 34530703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic mediators for ultrasound theranostics.
    Józefczak A; Kaczmarek K; Bielas R
    Theranostics; 2021; 11(20):10091-10113. PubMed ID: 34815806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Theranostic small interfering RNA nanoparticles in cancer precision nanomedicine.
    Chen Z; Krishnamachary B; Pachecho-Torres J; Penet MF; Bhujwalla ZM
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Mar; 12(2):e1595. PubMed ID: 31642207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are nanotheranostics and nanodiagnostics-guided drug delivery stepping stones towards precision medicine?
    Blau R; Krivitsky A; Epshtein Y; Satchi-Fainaro R
    Drug Resist Updat; 2016 Jul; 27():39-58. PubMed ID: 27449597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theranostic Applications of Nanomaterials in Alzheimer's Disease: A Multifunctional Approach.
    Tripathi P; Shukla P; Bieberich E
    Curr Pharm Des; 2022; 28(2):116-132. PubMed ID: 34809540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Assessment of In-vitro and In-vivo Evaluation Methods for Theranostic Nanomaterials.
    Parashar P; Singh N; Alka ; Maurya P; Saraf SA
    Curr Pharm Des; 2022; 28(2):78-90. PubMed ID: 34348616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theranostics - a sure cure for cancer after 100 years?
    Song Y; Zou J; Castellanos EA; Matsuura N; Ronald JA; Shuhendler A; Weber WA; Gilad AA; Müller C; Witney TH; Chen X
    Theranostics; 2024; 14(6):2464-2488. PubMed ID: 38646648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand Chemistry in Antitumor Theranostic Nanoparticles.
    Lin G; Zhang M
    Acc Chem Res; 2023 Jun; 56(12):1578-1590. PubMed ID: 37220248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.